Evidence map›Paper›PMID 26823869›Full record

ArticleInternational journal of clinical and experimental pathology2015

Investigation on the association between inerleukin-10 -592C/A, 819C/T and -1082A/G gene polymorphisms and development of diabetic nephrophathy.

Qingfeng Yin, Qianqian Zhai, Di Wang, Jie Hai, Meng Cao, Jianling Wang, Tao Wang

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Qingfeng YinDepartment of Endocrinology, The First Affiliated Hospital of Xinxiang Medical University Weihui 453100, Henan, China.
Qianqian ZhaiDepartment of Endocrinology, The First Affiliated Hospital of Xinxiang Medical University Weihui 453100, Henan, China.
Di WangDepartment of Endocrinology, The First Affiliated Hospital of Xinxiang Medical University Weihui 453100, Henan, China.
Jie HaiDepartment of Endocrinology, The First Affiliated Hospital of Xinxiang Medical University Weihui 453100, Henan, China.
Meng CaoDepartment of Endocrinology, The First Affiliated Hospital of Xinxiang Medical University Weihui 453100, Henan, China.
Jianling WangDepartment of Endocrinology, The First Affiliated Hospital of Xinxiang Medical University Weihui 453100, Henan, China.
Tao WangDepartment of Endocrinology, The First Affiliated Hospital of Xinxiang Medical University Weihui 453100, Henan, China.
First Affiliated Hospital of Xinxiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted a case-control study to investigate the association between interleukin (IL)-10-592C/A, -819C/T and -1082A/G polymorphisms and susceptibility to diabetic nephropathy. A hospital-based case-control study was taken in our study. A total of 172 patients with proven type 2 diabetes mellitus and 344 controls were recruited from the First Affiliated Hospital of Xinxiang Medical University between March 2012 and October 2014. Genotyping of IL-10 -592C/A, -819C/T and -1082A/G polymorphisms was done by done by PCR-RFLP methods. By the χ(2) test, the distributions of the GG, GA and AA genotypes in IL-10 -1082A/G were significantly different between patients with diabetic nephropathy and control subjects (χ(2) = 8.09, P = 0.02). By conditional logistic regression analysis, we found that the AA genotype of IL-10 -1082A/G was associated with an elevated risk of diabetic nephropathy compared to the GG genotype in codominant model, and the adjusted OR (95% CI) was 2.38 (1.23-4.57). In dominant model, the GA+AA genotype was associated with a significantly increased risk of diabetic nephropathy compared to the GG genotype in dominant model (OR = 1.47, 95% CI = 1.05-2.16). In recessive model, the AA genotype could influence the susceptibility to diabetic nephropathy when compared with the GG+GA in recessive model (OR = 2.08, 95% CI = 1.12-3.85). In conclusion, we suggested that IL-10 -1082A/G gene polymorphism was correlated with development of diabetic nephropathy, but no association was observed between IL-10 -819T/C and -592A/C and risk of diabetic nephropathy.

Indexed as

AdultAgedCase-Control StudiesDiabetes Mellitus, Type 2Diabetic NephropathiesFemaleGenetic Predisposition to DiseaseGenotypeHumansInterleukin-10MaleMiddle AgedPolymerase Chain ReactionPolymorphism, Restriction Fragment LengthPolymorphism, Single NucleotideIL10 protein, humanInterleukin-10Diabetic nephropathyIL-10 -1082A/GIL-10 -592A/CIL-10 -819T/Cpolymorphism

Identifiers

PMID26823869
PMCPMC4713655
OpenAlexW2261860472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.